GREY — Grey Matters Health Share News
0.000.00%
Last trade - 00:00- CA$3.95m
- CA$4.69m
Brief: Algernon Scales Up Manufacturing Of Np-120 (Ifenprodil) To Prepare For Coronavirus And Acute Lung Injury U.S. Clinical Trials
Brief: Algernon Explores The Use Of NP-120 As A Novel Treatment For Coronavirus
Brief: Algernon Pharmaceuticals Announces Increase And Closing Of Cdn$1.55 Mln Private Placement
Brief: Algernon Pharmaceuticals Announces Private Placement
Brief: Algernon Pharmaceuticals Appoints Jacky Smith To Its Medical And Scientific Advisory Board
Brief: Algernon Pharmaceuticals Provides Update On Its Planned Phase II Clinical Trial
Brief: Algernon Pharma To Offer Between 22.7 Mln Units And 45.5 Mln Units Of Co At Price Of $0.11 Per Unit
Brief: Algernon Says Lead Drugs For NASH And Chronic Kidney Disease Are Bemethyl And Bromantane
Brief: Algernon Pharmaceuticals Announces NP-120, Its Lead Compound In Idiopathic Pulmonary Fibrosis (IPF) Research Program, Is A Drug Called Ifenprodil
Brief: Algernon Pharmaceuticals Appoints Dr. Walter Reinisch To Its Medical And Scientific Advisory Board
Brief: Breathtec Biomedical Provides Development Update On Breathalyzer For Disease Detection